November 2013

CLAO E-NEWS November 2013: 



CLAO will be hosting the following educational programs at the 2013 American Academy of Ophthalmology Annual Meeting in New Orleans: A two-hour Contact Lens Skills Transfer Course on Sunday, Nov. 17 from 9:30-11:30 am in Room 350-351; a 90-minute Symposium entitled "Keratoconus: Past, Present and Future" on Sunday, Nov. 17 from 2:00-3:30 pm in Room 243-245; and a Didactic Course entitled "Contact Lenses in the Ophthalmology Practice from 4:30-5:30 pm on Sunday, Nov. 17 in Room 209. For information on the AAO Program visit


CLAO recently updated its website. A significant benefit of CLAO Membership includes the opportunity to provide practice contact information on the site. However, many members have not yet added their name, address, phone, or practice website information to the new site. All members are encouraged to take a minute to update their practice information on the site (Please note that your login and password does not affect your current login credentials for the CLAO Journal, Eye and Contact Lenses).


CLAO invites you to attend their International Symposium & Congress, to be held June 12-14, 2014 at the InterContinental Centre Hotel in Toronto, Canada. Programming is being developed by Dr. Deborah Jacobs, Scientific Programs Chair, along with the CLAO Scientific Programs Committee. Clinicians and researchers in the fields of contact lens, anterior segment, and ocular surface disease from the United States, Canada, and around the world will be presenting the latest advances. Topics covered will include:

What's New for Keratoconus


  • Corneal Collagen Crosslinking: International Update
  • Specialty Soft Lenses and Hybrid Lenses
  • Scleral RGP Lenses
  • Orthokeratology: Threat or Opportunity?
  • Aspherics, Wavefront-Optimized Contact Lenses, and Wavefront-Guided Contact Lenses
  • Choosing an IOL: Imaging, Optics, Visual Acuity and Visual Function
  • Contact Lens as Part of Your Practice: Business Aspects of Prescribing and Dispensing
  • Risk Management/Ethics
  • Contact Lens as a Therapeutic Platform
    • Drug Delivery
    • Myopia Control
    • Contact Lens Discomfort: New Options, New Directions


The meeting will also feature Professor Donald TH Tan, FRCS, who will present the Oliver H. Dabezies, Jr, MD, Lecture; Allan R. Slomovic, MD, FRCSC, who will present the Harold A. Stein, MD, Lecture; and Karla Zadnik, OD, PhD, who will be the program's Keynote presenter.

We hope you will join us for 2 days of outstanding education while enjoying the beauty and culture of cosmopolitan Toronto!

Additional program information and registration will be available soon at


The Contact Lens Association of Ophthalmologists Education and Research Foundation (CLAO ERF) in association with the Sjögren's Syndrome Foundation (SSF) announces the availability of a Scientific Research Grant to be awarded on December 31, 2013.


  • This award will be for $3,000 and is intended to provide support for proposals specifically concerned with issues directly related to dry eye and ocular surface disease.
  • The anticipated research term is three to six months.
  • The applicant must be working towards an advanced degree doing research in the United States.
  • Qualified applicants may request a grant application from our website at, via email at, or download the application here



A report on GP lenses that appeared in the October issue of Contact Lens Spectrum by Edward S. Bennett, OD, MSEd, FAAO stated that "The 2013 market for GP lenses is viable and may, in fact, be growing. While the application of spherical GP lenses on healthy eyes is decreasing as a result of advancements in specialty GP designs, GP lens use (including hybrids) in the United States has increased from 9% (Nichols, 2012) at the end of 2011 to 11% (Nichols, 2013) at the end of 2012. Internationally, the GP market remains steady, with 10% (Efron, 2013) to 12% (Morgan, 2013) of all contact lens patients worldwide fit into this modality."

The report further stated that "The scleral lens market continues to demonstrate ongoing dramatic growth. It is apparent that some of this growth in scleral lenses is a result of their successful crossover from a modality limited mainly to irregular cornea and dry eye patients to one that also includes the correction of healthy eyes, notably astigmatic and presbyopic patients. In addition, orthokeratology GP lenses, along with peripheral plus power soft lens designs, continue to demonstrate an effect on eye growth. These designs will continue to gain in popularity as their ability to induce myopic defocus, and therefore reduce myopia progression, is optimized. GP multifocal lens designs continue to evolve with continuing introductions of higher add power aspheric designs, notably incorporating add power on the front lens surface."

In summary the report concluded: "It is evident that GP lens use is stable in today's market, largely as a result of the impact that new scleral lens designs have recently exhibited-not only with dry eyes and irregular corneas, but also with astigmatic and presbyopic patients. In addition, the GP market has benefitted from the introduction of new and innovative multifocal designs, as well as the ongoing myopia research indicating that OOK can slow down axial length growth. These trends should continue not only through the remainder of 2013, but well into the future." The full report may be accessed at:


The Brien Holden Vision Institute (the Institute) released A Vision for All to See: A Report on Global Eye Health and Vision Care, aimed to raise awareness of the impending crisis of myopia and presbyopia and to create a call to action that prioritizes this growing issue. According to the Institute, in North America, more than 25 million people suffer from vision impairment due to uncorrected distance and near refractive error. Two of the most rapidly increasing refractive error conditions are myopia and presbyopia. The report indicates that in the past 30 years, the number of impacted by myopia in the U.S. among those aged 12 to 54 years has nearly doubled, growing from 25% in the early 1970s to 42% today (34 million people). As a result of the world's aging population and increased life expectancy, presbyopia is also on the rise. In 2010, the condition affected more than 143 million people in the U.S. and is estimated to grow to 1.5 billion worldwide by 2050. The report indicates that, in addition to the human costs, global lost productivity resulting from vision impairment, specifically uncorrected refractive error, is estimated at U.S. $202 billion. What it also pointed out is that even in the U.S., not everyone has access to eye care, and there are vast disparities by race, education and income. As reported by the Institute, studies show that from 1999 to 2008, people with less education and lower income were both less likely to visit an optometrist and less able to afford glasses when needed. The same study also found that more than 50% of Medicare beneficiaries had not visited an eye care provider or received an annual eye test. For more information on this report visit


Resources are available for ophthalmologists preparing for board certification or re-certification at Ophthalmologists will find several excellent Board Reviews at the Ophthalmology Board Reviews section of, In addition, those Ophthalmologists completing CME requirements will find additional CME activities on the Ophthalmology Page,,, now has links to more than 325 Online CME sites offering more than 16,000 CME courses and more than 26,000 hours of CME credit in over 50 medical areas. The List is updated regularly as new online CME sites and courses become available. There is no charge for accessing the List and no registration is required.


Information in this section has been provided to CLAO by press releases, online sources and other means. CLAO does not warranty its accuracy; nor does notice of a product in this section constitute an endorsement by CLAO.

Alcon has sponsored two supplements in the Contact Lens Spectrum. One is entitled Daily Disposable Water Gradient Lenses and can be viewed at The other is entitled "Respecting and Stabilizing the Tear Film" and can be viewed at

Pacific University Libraries offers a book entitled A Guide to Scleral Lens Fitting. This publication covers all aspects of fitting today's modern scleral contact lenses. Complimentary access to this publication is available at The U.S. Environmental Protection Agency (EPA) is working to educate patients in regard to contact lens safety and care. On the EPA website is a document entitled, "Do You Wear Contact Lenses? - There's Something You Should Know..." It covers information on Acanthamoeba based on data from the Centers for Disease Control (CDC). To view this document (it is in easy to read question and answer format) visit The U.S. Food and Drug Administration is urging ophthalmologists to report occurrences of adverse patient reactions caused by decorative contact lenses to its MedWatch program. The FDA is emphasizing the need to report adverse reactions, especially if the lenses were purchased without a prescription, as the agency can only take action against illegal sellers when violations are reported. Consumers can report decorative lens-related problems directly to their local FDA Consumer Complaint Coordinator.
Vistakon, Johnson & Johnson Vision Care, Inc., (JJVCI), reported on September 23, 2013 that the company is now accepting research proposals related to ultraviolet (UV) radiation and the human eye. Specific areas of interest include the following topics:


  • Eye health including photoageing (cataractogenesis, presbyopia, corneal, retinal, conjunctival/limbal changes)
  • Epidemiology of UV induced ocular disease including geographic, ethnic, and occupational study. Proposals may include the study of indoor and outdoor UV radiation. Increased risk associated with UV exposure in youth.
  • Assessing the protective effect of UV blocking contact lenses on human ocular tissues including methodology, measurement techniques and clinical endpoints. Comparative protective effects of contact lenses and spectacles/sunglasses.


Research proposals must be submitted through the JJVCI Investigator Initiated Study (IIS) application process by contacting the Clinical Research Administrator by email at, or by calling at +1-904-443-1525. All research proposals must be submitted in English. For additional information on JJVCI's IIS process and policy, please go to the following link: In other news, the company on September 24, 2013 announced the appointment of Laura Angelini to the role of President, North America, Johnson & Johnson Vision Care, Inc. In her new role, Ms. Angelini will be responsible for the VISTAKON U.S. and Canadian businesses.

Mark Your Calendar

The 2013 American Academy of Ophthalmology (AAO) Annual Meeting is scheduled to take place November 15-19, in New Orleans, LA. JCAHPO holds its annual ACE meeting in conjunction with the AAO.

The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting is scheduled to take place April 25-29, 2014 in Boston, MA. For more information, visit

The CLAO International Symposium & Congress meeting is being planned by the CLAO Scientific Programs Committee to be held June 12-14, 2014 in Toronto, Canada. For more information, visit

Lens Financing

For fast and guaranteed financing for your eye correction lenses please visit

CLAO "Did You Know?"

Did you know that CLAO has two websites on the internet, one designed for members at and one designed for the public at and that both have been recently redesigned and updated for ease of use?

Contact Lens Event Reporting:

To report adverse contact lens reactions, visit the website or call (800) FDA-1088.
To report possible grievances related to the Fairness to Contact Lens Consumers Act or the associated Contact Lens Rule, click here.

Contact CLAO:

CLAO, 4000 Legato Road #700, Fairfax, VA. 22033
Phone: 855-264-8818 Fax: 703-434-3003 Email:
Web:, and